Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of biomarkers for cancer diagnosis, prognosis or prediction of treatment response, identification of new targets for cancer therapy, as well as development of new technologies for research and treatment of cancer are the major themes covered by both the educational series and research articles. A broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.

  • 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again

Journal information

Editor-in-Chief
  • Pere Gascon
Publishing model
Hybrid. Learn about publishing OA with us

Journal metrics

2.737 (2019)
Impact factor
2.470 (2019)
Five year impact factor
14 days
Submission to first decision
74 days
Submission to acceptance
245,431 (2019)
Downloads

Latest articles

Journal updates

  • Impact of COVID-19

    As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our usual peer review process. We thank referees for their continued support in these challenging times and ask authors for their patience and understanding.

    COVID-19
  • The Immune System and Cancer/Immunotherapy: Topical Collection

    The connection between the Immune System and Cancer has been always there, but only recently, it has been possible to uncover some vulnerable targets of the system, check-point inhibitors among others, that look very promising in cancer treatment.

    Check out the Topical Collection

View all updates

Societies, partners and affiliations

Subscribe

eJournal
$99.00
Note this is only the net price. Taxes will be calculated during checkout.
  • Immediate online access with complete access to all articles
  • Downloadable in PDF format
  • Subscription expires 12/31/2020

About this journal

Electronic ISSN
1699-3055
Print ISSN
1699-048X
Abstracted and indexed in
  1. CNKI
  2. Chemical Abstracts Service (CAS)
  3. Dimensions
  4. EBSCO Discovery Service
  5. EMBASE
  6. Google Scholar
  7. INIS Atomindex
  8. Institute of Scientific and Technical Information of China
  9. Japanese Science and Technology Agency (JST)
  10. Journal Citation Reports/Science Edition
  11. Medline
  12. Naver
  13. OCLC WorldCat Discovery Service
  14. ProQuest-ExLibris Primo
  15. ProQuest-ExLibris Summon
  16. Reaxys
  17. SCImago
  18. SCOPUS
  19. Science Citation Index Expanded (SciSearch)
  20. Semantic Scholar
  21. TD Net Discovery Service
  22. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Federación de Sociedades Españolas de Oncología (FESEO)